The entry of Norges Bank, a sovereign investor with long-term horizon, combined with Wells Fargo doubling its stake, suggests growing conviction in Alnylam's valuation or pipeline. Traders should monitor for follow-on buys and upcoming clinical or regulatory catalysts.
ALNY drugs
ALNY drug pipeline →- ● brezosiran 3/10 Phase 1b
- ● GIVLAARI 3/10 Approved (FDA approval 2019-11-20)
- ● ONPATTRO 3/10 Approved (marketed); Phase 3 (APOLLO-B) completed
- ● OXLUMO 3/10 Approved
- ● ALN-6222 2/10 unknown (no registered ClinicalTrials.gov record found; appears to be an early, minimally disclosed pipeline program)
- 2 more · All ALNY drugs, catalysts & trials →
How the stock moved after the report
BULLISH VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Mar 2 $325.07entry
- T+1 · 9mo ago −1.98%α −1.06% · $318.65
- T+5 · 8mo ago −0.46%α +0.75% · $323.59
- T+20 · 8mo ago −2.76%α +5.18% · $316.09
- T+60 · 6mo ago −9.10%α −18.42% · $295.50
How similar events traded
Executive Summary
Three major institutions, including sovereign wealth fund Norges Bank, accumulated $1.06B in new positions in Alnylam Pharmaceuticals during Q4 2025, while BofA trimmed its stake by over half, reducing its position by $502.4M. The cluster shows strong net buying, led by a new $895.8M position from Norges Bank, signaling renewed institutional confidence despite one large passive seller.
Key Financial Metrics
Institutional Positions
Net institutional flow: $560.6M
▲ Buyers (3)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Norges Bank | NEW | +0% | $895.8M | $895.8M |
| Morgan Stanley | ADD | +33.6% | $385.8M | $54.7M |
| Wells Fargo | DOUBLED | +108.8% | $249.6M | $112.5M |
▼ Sellers (1)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| BofA | TRIM | -59.7% | $774.8M | -$502.4M |
Key Facts
- Norges Bank established a new $895.8M position in ALNY, the largest single buyer in the cluster.
- Morgan Stanley increased its stake by 33.6% ($54.7M net addition), and Wells Fargo doubled its position (+108.8%, $112.5M net addition).
- BofA significantly trimmed its holding by 59.7%, exiting $502.4M in value.
- Net institutional inflow of $557.6M ($1.53B total holdings, $1.06B in net buying vs $502.4M in selling).
Financial Impact
3 institutions accumulated $1.06B in new positions while 1 reduced holdings by $502.4M, resulting in a net $557.6M institutional inflow.
Risk Factors
- BofA's large trim may indicate profit-taking or risk-off behavior among some large passives.
- The cluster is dominated by passive managers; only Norges Bank is an active sovereign investor, which may limit the strength of the signal.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-ALNY-2025-Q4 |
Track record
15 reports on ALNY
1 of 4 bullish or bearish reports moved the stock their way by T+5. Best: +26.35% at T+5 after the Oct 23, 2026 report. 1 of 4 went positive at some point.
Filters
- Nov 16, 2026today SC 13G Neutral 3/10 Entry $160.53 settles Nov 23
- Nov 13, 20263d ago SC 13G/A Neutral 2/10 Entry $165.50 settles Nov 23
- Nov 13, 20263d ago SC 13G/A Neutral 2/10 Entry $165.04 settles Nov 20
- Nov 12, 20264d ago Insider Cluster Neutral 2/10 Entry $165.04 settles Nov 20
- Nov 5, 202611d ago SC 13G/A Neutral 3/10 Entry $156.66 to $156.65 ▼ −0.01% −3.30% vs SPY
- Nov 5, 202611d ago 8-K Neutral 4/10 Entry $156.66 to $156.65 ▼ −0.01% −3.30% vs SPY
- Oct 30, 202617d ago SC 13G Neutral 3/10 Entry $165.00 to $155.94 ▼ −5.49% −2.79% vs SPY
- Oct 29, 202618d ago 8-K Bullish 6/10 Entry $174.00 to $156.66 ▼ −9.97% −5.24% vs SPY
- Oct 23, 202624d ago Institutional Cluster Bearish 4/10 Entry $224.03 to $165.00 ▲ +26.35% +25.79% vs SPY
- Aug 17, 202613w ago Court Ruling Neutral 4/10 Entry $228.61 to $240.08 ▲ +5.02% +5.22% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers